Aqueous Synthesis of Poly(ethylene glycol)‐Amide‐Norbornene‐Carboxylate for Modular Hydrogel Crosslinking
Nathan H. Dimmitt,
No information about this author
Chien‐Chi Lin
No information about this author
Advanced Materials Interfaces,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 5, 2025
Abstract
Poly(ethylene
glycol)‐norbornene
(e.g.,
PEGNB)
is
a
versatile
macromer
amenable
to
step‐growth
thiol‐norbornene
photopolymerization
and
inverse
electron
demand
Diels–Alder
(iEDDA)
click
reaction.
The
translational
potentials
of
PEGNB‐based
hydrogels
have
been
realized
in
the
areas
stem
cell
differentiation,
vitro
disease
modeling,
implantable
therapeutic
devices,
controlled
release
therapeutics.
Even
with
these
advances,
prior
methods
for
synthesizing
PEGNB
all
required
heavy
use
organic
solvents
that
pose
significant
environmental
personal
health
burdens.
Here,
an
all‐aqueous
synthesis
PEG‐amide‐norbornene‐carboxylate
(PEGaNB
CA
)
reported
via
reacting
carbic
anhydride
(CA)
multi‐arm
amino‐terminated
PEG.
Like
previously
ester‐bearing
counterparts
(i.e.,
PEGeNB
),
PEGaNB
readily
crosslinked
into
modular
by
either
or
tetrazine‐norbornene
iEDDA
Unlike
its
counterparts,
provided
long‐term
hydrolytic
stability.
However,
through
blending
hydrolytically
labile
,
can
be
engineered
undergo
tunable
degradation.
versatility
further
demonstrated
high‐fidelity
digital
light
processing
printing
situ
encapsulation
maintenance
human
induced
pluripotent
cells
(hiPSCs).
Language: Английский
Methods to achieve tissue-mimetic physicochemical properties in hydrogels for regenerative medicine and tissue engineering
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(35), P. 8505 - 8522
Published: Jan. 1, 2024
Hydrogels
are
limited
by
their
inability
to
recapitulate
native
extracellular
physicochemical
properties.
Current
efforts
using
advanced
materials
science
and
engineering
methods
seek
form
hydrogels
with
physiologically-relevant
Language: Английский
Impact of Annealing Chemistry on the Properties and Performance of Microporous Annealed Particle Hydrogels
Sarea Y. Recalde Phillips,
No information about this author
Kiara D. Perez-Ponce,
No information about this author
Elizabeth Ruben
No information about this author
et al.
Biomacromolecules,
Journal Year:
2024,
Volume and Issue:
25(9), P. 5798 - 5808
Published: Aug. 27, 2024
Microporous
annealed
particle
(MAP)
hydrogels
are
a
promising
class
of
in
situ-forming
scaffolds
for
tissue
repair
and
regeneration.
While
an
expansive
toolkit
annealing
chemistries
has
been
described,
the
effects
different
on
MAP
hydrogel
properties
performance
have
not
studied.
In
this
study,
we
address
gap
through
controlled
head-to-head
comparison
poly(ethylene
glycol)
(PEG)-based
that
were
using
tetrazine-norbornene
thiol-norbornene
click
chemistry.
Characterization
material
revealed
tetrazine
significantly
increases
shear
storage
modulus
results
slower
vitro
degradation
kinetics
when
microgels
with
higher
cross-link
density
used.
However,
these
muted
fabricated
from
lower
density.
contrast,
vivo
testing
murine
critical-sized
calvarial
defects
differences
physicochemical
do
translate
to
bone
volume
or
defect
healing
growth-factor-loaded
implanted
into
mouse
defects.
Nonetheless,
impact
could
be
important
other
applications
should
investigated
further.
Language: Английский
Injectable long-acting formulations (ILAFs) and manufacturing techniques
Kosheli Thapa Magar,
No information about this author
Hamza Boucetta,
No information about this author
Zongmin Zhao
No information about this author
et al.
Expert Opinion on Drug Delivery,
Journal Year:
2024,
Volume and Issue:
21(6), P. 881 - 904
Published: June 2, 2024
Most
therapeutics
delivered
using
short-acting
formulations
need
repeated
administration,
which
can
harm
patient
compliance
and
raise
failure
risks
related
to
inconsistent
treatment.
Injectable
long-acting
(ILAFs)
are
controlled/sustained-release
fabricated
deliver
active
pharmaceutical
ingredients
(APIs)
extend
their
half-life
over
days
months.
Longer
half-lives
of
ILAFs
minimize
the
necessity
for
frequent
doses,
increase
compliance,
reduce
risk
side
effects
from
intravenous
(IV)
infusions.
Using
ILAF
technologies,
immediate
drug
release
also
be
controlled,
thereby
minimizing
potential
adverse
due
high
initial
blood
concentrations.
Language: Английский